Intelligence · Clinical Development
Pipeline search results
Programs matching “oncology” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 189 pipeline programs matching "oncology" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Cytarabine
Kura Oncology
Acute Myeloid Leukemia
1 trial -
Dexamethasone
Kura Oncology
Lymphoblastic Leukemia
1 trial -
Dupilumab
Coherus Oncology
Metastatic Colorectal Cancer
1 trial -
Evorpacept (ALX148)
ALX ONCOLOGY HOLDINGS INC
Microsatellite Stable Metastatic Colorectal Cancer
1 trial -
Evorpacept (ALX148)
ALX ONCOLOGY HOLDINGS INC
Breast Cancer, Metastatic
1 trial -
FOLFIRI regimen
Cardiff Oncology
Colorectal Cancer
1 trial -
Functional Precision Oncology
United Therapeutics Europe Ltd
Breast Cancer Recurrent
1 trial -
Hydrocortisone acetate and lidocaine hydrochloride
CITIUS ONCOLOGY, INC.
Hemorrhoids
1 trial -
IB 2021-03
The George Institute
Adult patients with intermediate unfavorable risk prostate cancer as per NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines Prostate Cancer. Version 2.2021)
1 trial -
Infigratinib
BridgeBio Oncology Therapeutics
Hypochondroplasia
1 trial -
Infigratinib
BridgeBio Oncology Therapeutics
Achondroplasia
1 trial -
Infigratinib 0.016 mg/kg
BridgeBio Oncology Therapeutics
Achondroplasia
1 trial -
Infigratinib is provided as a single dose of minitablets for oral administration
BridgeBio Oncology Therapeutics
Achondroplasia
1 trial -
Ivaltinostat
CG Oncology
Metastatic Pancreatic Adenocarcinoma
1 trial -
KEYTRUDA 25 mg/mL concentrate for solution for infusion
Cardiff Oncology
Anal cancer
1 trial -
LAB4
Cardiff Oncology
Graves' Disease
1 trial -
Leucovorin
Cardiff Oncology
Colorectal Cancer
1 trial -
Liposomal Irinotecan
United Therapeutics Europe Ltd
Oncology
1 trial -
Low Molecular Weight Heparin (LMWH)
Cardiff Oncology
Cancer
1 trial -
MRx0518
4D Molecular Therapeutics
Oncology
1 trial -
Monad 1
CITIUS ONCOLOGY, INC.
Hemorrhoids
1 trial -
Motivational Interviewing
Cardiff Oncology
Diabetes Mellitus
1 trial -
NY-ESO-1 Peptide vaccine
Coherus Oncology
Ovarian Cancer Stage IV
1 trial -
Nadunolimab
Coherus Oncology
Metastatic Microsatellite Stable Colorectal Carcinoma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.